Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1126117 | 0.90 | KDM4E (0.39) | ALDH1A1CYP2D6KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL1126079 | 0.86 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1KMT2AKDM4EMEN1 | |
| SCHEMBL1126099 | 0.82 | SMN1; SMN2 (0.48) | ALDH1A1L3MBTL1KMT2AHPGDMEN1 | |
| SCHEMBL3316970 | 0.75 | ALDH1A1 (0.39) | ALDH1A1KMT2AKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL1126491 | 0.75 | KMT2A (0.39) | ALDH1A1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL3316965 | 0.72 | PARP1 (0.35) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL1126343 | 0.72 | RAB9A (0.33) | ALDH1A1 | |
| SCHEMBL1126086 | 0.72 | CYP1A2 (0.34) | ALDH1A1CYP2D6KMT2AHPGDKDM4E | |
| SCHEMBL11109785 | 0.71 | MAPT (0.31) | ALDH1A1KMT2AHPGDKDM4EMEN1 | |
| SCHEMBL17770528 | 0.71 | L3MBTL1 (0.40) | ALDH1A1L3MBTL1KMT2AKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240132796-A1 | TRIBOLOGICAL SYSTEM | KLUEBER LUBRICATION MUENCHEN SE & CO. KG (DE) | 2024-04-25 | — | — | US | claimed |
| US-11905483-B2 | Tribological system | KLUEBER LUBRICATION MUENCHEN SE & CO. KG (DE) | 2024-02-20 | — | — | US | claimed |
| WO-2024017517-A1 | LUBRICANT COMPOSITION CONTAINING AN IONIC LIQUID | KLUEBER LUBRICATION MUENCHEN SE & CO. KG (DE) | 2024-01-25 | — | — | WO | claimed |
| EP-4239039-A1 | LUBRICATING COMPOSITION COMPRISING AN IONIC LIQUID | Klüber Lubrication München SE & Co. KG (DE) | 2023-09-06 | — | — | EP | claimed |
| US-20230063820-A1 | TRIBOLOGICAL SYSTEM | KLUEBER LUBRICATION MUENCHEN SE & CO. KG (DE) | 2023-03-02 | — | — | US | claimed |
| EP-4100558-A1 | TRIBOLOGICAL SYSTEM | Klüber Lubrication München SE & Co. KG (DE) | 2022-12-14 | — | — | EP | claimed |
| EP-4073213-A1 | USE OF A LUBRICATING GREASE COMPOSITION HAVING A HIGH UPPER USE TEMPERATURE | Klüber Lubrication München SE & Co. KG (DE) | 2022-10-19 | — | — | EP | claimed |
| WO-2021115685-A1 | USE OF A LUBRICATING GREASE COMPOSITION HAVING A HIGH UPPER USE TEMPERATURE | KLUEBER LUBRICATION MUENCHEN SE & CO. KG (DE) | 2021-06-17 | — | — | WO | claimed |
| US-20100105586-A1 | LUBRICATING GREASE COMPOSITION | KLUBER LUBRICATION MUNCHEN KG (DE) | 2010-04-29 | — | — | US | claimed |
| EP-1420012-B1 | Process for the preparation of aliphatic isocyanates from aromatic isocyanates | DEGUSSA (DE) | 2006-11-02 | — | — | EP | claimed |
| EP-4384589-A1 | USE OF HEMIMELLITIC ESTER AS A BASE OIL FOR LUBRICANT COMPOSITIONS | Klüber Lubrication München SE & Co. KG (DE) | 2024-06-19 | — | — | EP | disclosed |
| US-20240132796-A1 | TRIBOLOGICAL SYSTEM | KLUEBER LUBRICATION MUENCHEN SE & CO. KG (DE) | 2024-04-25 | — | — | US | disclosed |
| US-11905483-B2 | Tribological system | KLUEBER LUBRICATION MUENCHEN SE & CO. KG (DE) | 2024-02-20 | — | — | US | disclosed |
| EP-3913039-B1 | BLEND OF ESTER COMPOUNDS | KLUEBER LUBRICATION MUENCHEN SE & CO KG (DE) | 2024-01-31 | — | — | EP | disclosed |
| WO-2024017517-A1 | LUBRICANT COMPOSITION CONTAINING AN IONIC LIQUID | KLUEBER LUBRICATION MUENCHEN SE & CO. KG (DE) | 2024-01-25 | — | — | WO | disclosed |
| US-8258088-B2 | Lubricating grease composition | KLüBER LUBRICATION MüNCHEN KG (DE) | 2012-09-04 | — | — | US | disclosed |
| EP-2282995-A1 | DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS | Novartis AG (CH) | 2011-02-16 | — | — | EP | disclosed |
| US-20100105667-A1 | Quinoxaline- and Quinoline-Carboxamide Derivatives | NOVARTIS AG | 2010-04-29 | — | — | US | disclosed |
| US-20100105586-A1 | LUBRICATING GREASE COMPOSITION | KLUBER LUBRICATION MUNCHEN KG (DE) | 2010-04-29 | — | — | US | disclosed |
| WO-2009141386-A1 | DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS | NOVARTIS AG (CH) | 2009-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105667-A1 | Quinoxaline- and Quinoline-Carboxamide Derivatives | ABL1, NQO2, MAP4K5 | ALDH1A1 2916/4885CYP2D6 192/4885L3MBTL1 4384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.